At a Glance
Regime: Bounce · Open: Gap up · Risk on new positions: High · Custom T2108: 49.0, rising
Focus: RSKD (Earnings Catalyst · Duration)
Secondary: N/A
Tonight After Hours: ALVO, DDI, NFGC · Tomorrow Before Open: ABSI, ADIG, AVAH, EPC, NBIS★, NIQ, SPB · ★ = Market Mover
Holding: DCTH, VIR
Situational Awareness
Market Condition: Bounce
Commentary: Big gap up again in the market. CRWV★ positive earnings last night. Most tech still just looks like Mean Reversion though. Cautious still here. Many charts continue to be broken and how we close will be much more important than how we open. Negative inflation data yesterday and potential FED rate rises are not bullish.
Going through Gainers and Strong stocks the last few weeks there is continuation in certain names. So there are opportunities occurring. Just need to remain selective and not get caught up in any FOMO on a mean reversion rally in many names.
Main pick below. Also watching a total China Pump and Dump INLF for potential Supernova type move on a Robotics Investment headline. (Highly speculative and risky)
★ = Market Mover
Situational Awareness · 11th November 2026
Today In Focus
RSKD — Riskified: Riskified Reports Strong Third Quarter of 2026 with Accelerating Revenue and Gross Profit Growth
Earnings Catalyst · Duration · Mkt cap $1.1B · Float 102M · SI 1.0% (1.0 days) · NYSE · Theme: Fintech > Payment Processing · Next earnings N/A
Why: Trifecta Beat. In Theme (Agentic Cyber Security). Accelerating Revs, Beat on EPS, Raised Guidance on EBITDA and Revs. New Partnership with Zendesk.
◾ Earnings Highlights
Q3 Results
◾ Revenue: $115.2M (Est. $104.5M; range $103.4–105.5M; +10.3%) 🟢; +41% YoY ⚡ ACCEL — YoY growth 4% → 6% → 7% → 22% → 41% (Q3'25 to Q3'26)
◾ Adj. (non-GAAP) diluted EPS: $0.07 (Est. $0.035; range $0.03–0.04; +100%) 🟢; vs $0.04 a year ago
◾ GAAP EPS: −$0.01 (GAAP Est. −$0.04; +75%) 🟢; vs −$0.05
◾ GAAP gross margin: 43%; −700 bps YoY. Non-GAAP: 43%, −800 bps
◾ Adj. EBITDA: $8.1M, +47%; margin 7%, flat YoY
◾ GAAP operating loss: −$2.5M vs −$9.0M
◾ Free cash flow: $15.2M (record) vs $13.4M
◾ GMV: $44.6B, +18%. Take rate 0.258% vs 0.217% (my calculation)
◾ Digital Finance billings: >300% YoY. Electronics, General and Home together: +12%
◾ Cash, deposits and investments: $234.9M · Total debt: $0
FY2026 Guidance (third raise this year; no current consensus retrieved)
◾ Revenue: $427–433M (midpoint $430M); raised from $400–410M
◾ Adj. EBITDA: $39–43M (midpoint $41M); raised from $33–39M
Other Announcements
◾ Launched Agent Identity Risk Intelligence, which identifies the AI agent behind an order or service request
◾ New partnership with Zendesk
◾ Buybacks: $2.3M in Q3, $94.1M year to date
Level: $10 U&R or Pre Market High around $10.50 Area likely entry.
Also in Play
Catalyst Winners 2026: TradingView
Trade Updates
Open:
DCTH - Earnings Catalyst - 9th November 2026 - 100% Remaining
VIR - Biotech Catalyst - 9th November 2026 - 100% Remaining
Closed:
PEPG - Biotech Catalyst - 10th November 2026 - Stopped Out - +1.32%
PXLW - PR Catalyst - 10th November 2026 - Stopped Out - -8.32%
Macro Events (Eastern Time)
Wednesday November 11 2026
5:00 AM - OPEC Monthly Report
7:00 AM - MBA 30-Year Mortgage Rate (Nov/06) (Previous: 7.3%)
IPOs Today
N/A
Biotech Calendar
XBI +0.06% on the week and +2.42% on the month, above its 50-day.
Coming up: Thu 12 Nov · NERV (Minerva Neurosciences, Inc.) · Readout
Note: Never front-run biotech catalysts. Wait for the catalyst to hit, then assess if the reaction is tradable. Dates are estimates and can shift.
Full H2 Biotech Watchlist: TradingView
Have a Great Day!
Sean Sharpe
